Safety, efficacy, and operability of a newly developed absorbable adhesion barrier (GM142) in patients with primary rectal cancer scheduled for diverting ileostomy during laparoscopic surgery: Randomized controlled trial
2018 ◽
Vol 24
(5)
◽
pp. e12660
◽
2020 ◽
Vol 48
(2)
◽
pp. 170-176